Remove Biophysical Assays Remove Drug Development Remove Pharmaceuticals
article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

We have several exciting projects in various stages of discovery, but a small-molecule drug that is causing a lot of excitement at the moment is Capivasertib. Capivasertib originated from a collaboration between my former company Astex Pharmaceuticals and the ICR and was further developed by AstraZeneca.